XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statement of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Revenue (Notes 1 and 11) $ 271,614 $ 244,182 $ 795,354 $ 718,993
Costs and Operating Expenses:        
Cost of revenue 150,175 138,456 441,066 404,671
Selling, general, and administrative expenses 69,043 57,889 209,352 176,441
Research and development expenses 3,409 3,324 10,621 10,102
Other costs (Note 3) 0 969 0 1,043
Total Costs and Operating Expenses 222,627 200,638 661,039 592,257
Operating Income 48,987 43,544 134,315 126,736
Interest Income 407 438 1,386 1,053
Interest Expense (5,516) (2,107) (15,386) (6,722)
Other Expense, Net (16) (20) (48) (62)
Income Before Provision for Income Taxes 43,862 41,855 120,267 121,005
Provision for Income Taxes (Note 5) 11,964 10,816 31,810 31,761
Net Income 31,898 31,039 88,457 89,244
Net Income Attributable to Noncontrolling Interests (312) (175) (891) (571)
Net Income Attributable to Kadant $ 31,586 $ 30,864 $ 87,566 $ 88,673
Earnings per Share Attributable to Kadant (Note 4)        
Basic (in dollars per share) $ 2.69 $ 2.64 $ 7.46 $ 7.58
Diluted (in dollars per share) $ 2.68 $ 2.63 $ 7.44 $ 7.57
Weighted Average Shares (Note 4)        
Basic (in shares) 11,745 11,706 11,737 11,697
Diluted (in shares) 11,780 11,740 11,763 11,719